Oryzon Genomics S.A. (LON:0RDB)
London flag London · Delayed Price · Currency is GBP · Price in EUR
3.115
-0.015 (-0.48%)
Feb 12, 2026, 11:33 AM GMT

Oryzon Genomics Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
21175100118120188
Market Cap Growth
174.24%-24.89%-15.50%-1.34%-36.45%75.69%
Enterprise Value
19982105114104161
Last Close Price
2.711.161.692.352.253.16
PS Ratio
32.7812.318.108.4813.4222.07
PB Ratio
-1.041.411.832.002.77
P/TBV Ratio
-1.041.411.852.022.78
EV/Sales Ratio
31.0813.408.538.1911.6618.92
Debt / Equity Ratio
-0.190.220.310.250.18
Asset Turnover
-0.070.140.160.110.11
Inventory Turnover
-67.1130.808.173.551.74
Quick Ratio
-0.740.871.343.755.47
Current Ratio
-0.750.871.343.765.51
Return on Equity (ROE)
--4.34%-4.35%-5.88%-6.37%-4.96%
Return on Assets (ROA)
--2.61%-2.71%-3.45%-4.63%-3.08%
Return on Invested Capital (ROIC)
-14.59%-4.71%-5.73%-7.98%-12.34%-10.01%
Return on Capital Employed (ROCE)
--4.60%-5.00%-6.50%-8.10%-5.00%
Earnings Yield
-1.14%-4.05%-2.92%-3.18%-3.29%-1.62%
FCF Yield
--6.28%-0.50%-1.44%-2.67%-2.37%
Buyback Yield / Dilution
-18.64%-6.35%-10.10%-4.80%--15.99%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.